Durvalumab vs Edoxaban

Durvalumab vs Edoxaban: Overview

This comparison examines the pharmacological differences between Durvalumab and Edoxaban.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Edoxaban: Direct, selective inhibitor of Factor Xa preventing thrombin generation and clot formation.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Edoxaban — 10-14 hours.

Chemical Properties

Molecular Formula: Edoxaban — C24H30ClN7O4S.

Molecular Weight: Edoxaban — 548.0530 g/mol.

Type: Durvalumab — Antibody; Edoxaban — Small molecule.